Publication date: 11th October 2013

Conclusions

• Cardio inCode® offers a cost-effective enhancement to traditional CHD risk assessment methods, especially for moderate-risk patients. It improves risk classification, particularly for those with moderate-high CHD risk, yielding significant cost-effectiveness benefits.